PT  - JOURNAL ARTICLE
AU  - Wahid, Abdul
AU  - Khan, Amjad
AU  - Iqbal, Qaiser
AU  - Khan, Asad
AU  - Mohammad, Nazar
TI  - The Epidemiology of COVID-19 and applying Non Pharmaceutical interventions by using the Susceptible, Infectious Recovered epidemiological Model in Pakistan
AID  - 10.1101/2020.05.08.20095794
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.08.20095794
4099  - http://medrxiv.org/content/early/2020/05/13/2020.05.08.20095794.short
4100  - http://medrxiv.org/content/early/2020/05/13/2020.05.08.20095794.full
AB  - Introduction The COVID-19 is caused by the virus known as sever acute respiratory syndrome corona virus 2 (SARS-CoV-2) having the common symptoms such as Flue, fever, dry cough and shortness of breath. The first case was reported in WUHAN city china in December 2019 and it spread to the whole world, WHO declared as world pandemic on 11th march 2020.SIR Epidemiological Model The first case in Pakistan was confirmed on 26th Feb 2020 as by the 8th April 2020 the total no of confirmed cases 4187 with 58 deaths and 467 recoveries throughout the country. The upcoming situation of the COVID-19 in Pakistan is forecasted by using SIR epidemiological, which is one of the mathematical derivative models with great accuracy rate prediction used for infectious disease. This model was introduced in the early 20th century.Results Pakistan is will be having a heavy burden of patients 80000 plus infected patients 45000 recoveries 10000 hospitalized 3000 ICU and 800 plus deaths in the next 20 days. A complete lock down, social distancing and imposing curfew to keep every person at home can save Pakistan from a very huge number 1000000 infected patients with huge number of causalities with next 2 months.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo Fund ReceivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data in this perspective will be made available.